Project Abstract

Abstract
MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation and have been implicated in various biological processes, including cancer progression and drug resistance. This research aims to explore the role of miRNAs in cancer progression and drug resistance, with a focus on understanding the underlying mechanisms and potential therapeutic implications. The study begins with a comprehensive review of the current literature on miRNAs in cancer, highlighting key miRNAs involved in promoting or inhibiting cancer progression and drug resistance. The literature review also discusses the mechanisms through which miRNAs regulate gene expression and impact cancer cell behavior. In the research methodology section, various experimental approaches are outlined, including cell culture studies, miRNA profiling, and functional assays to investigate the effects of specific miRNAs on cancer cell proliferation, migration, and drug response. In addition, bioinformatics analyses will be employed to identify potential miRNA targets and signaling pathways involved in cancer progression and drug resistance. The findings from this study are expected to provide valuable insights into the role of miRNAs in cancer biology and may identify novel therapeutic targets for cancer treatment. The discussion of findings will delve into the implications of the results, potential challenges, and future directions for research in this field. Furthermore, the significance of the study in advancing our understanding of cancer biology and the potential clinical applications of miRNA-based therapies will be highlighted. In conclusion, this research project represents a comprehensive investigation into the role of miRNAs in cancer progression and drug resistance. By elucidating the complex interplay between miRNAs and cancer biology, this study contributes to the growing body of knowledge on miRNA-based therapies for cancer treatment. Ultimately, the findings from this research have the potential to impact the development of novel therapeutic strategies for combating cancer progression and drug resistance.

Project Overview